CoChat
Sign Up
Cited by 105

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy

Yi, Yang, Hsieh, I-Yun, Huang, Xiaojia, Li, Jie, Zhao, Wei·2016·Frontiers in Pharmacology
DOI 10.3389/fphar.2016.00477PMC PMC5141588
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2016.00477

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 118

  1. Abdouh, 2009, BMI1 sustains human glioblastoma multiforme stem cell renewal., J. Neurosci., 29, 8884, 10.1523/JNEUROSCI.0968-09.2009 · DOI
  2. Alonso, 2011, Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas., PLoS ONE, 6, 10.1371/journal.pone.0026740 · DOI
  3. Anido, 2010, TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma., Cancer Cell, 18, 655, 10.1016/j.ccr.2010.10.023 · DOI
  4. Aum, 2014, Molecular and cellular heterogeneity: the hallmark of glioblastoma., Neurosurg. Focus, 37, 10.3171/2014.9.FOCUS14521 · DOI
  5. Bao, 2006, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor., Cancer Res., 66, 7843, 10.1158/0008-5472.CAN-06-1010 · DOI
  6. Bar, 2007, Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma., Stem Cells, 25, 2524, 10.1634/stemcells.2007-0166 · DOI
  7. Baxter, 2014, Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes., Acta Neuropatho.l Commun., 2, 10.1186/s40478-014-0160-4 · DOI
  8. Bhat, 2011, The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma., Genes Dev., 25, 2594, 10.1101/gad.176800.111 · DOI
  9. Bradshaw, 2016, Cancer stem cell hierarchy in glioblastoma multiforme., Front. Surg., 3, 10.3389/fsurg.2016.00021 · DOI
  10. Bruggeman, 2007, Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma., Cancer Cell, 12, 328, 10.1016/j.ccr.2007.08.032 · DOI
  11. Calabrese, 2007, A perivascular niche for brain tumor stem cells., Cancer Cell, 11, 69, 10.1016/j.ccr.2006.11.020 · DOI
  12. Chang, 2009, Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier., Int. J. Pharm., 379, 285, 10.1016/j.ijpharm.2009.04.035 · DOI
  13. Chen, 2012, Modern methods for delivery of drugs across the blood-brain barrier., Adv. Drug Deliv. Rev., 64, 640, 10.1016/j.addr.2011.11.010 · DOI
  14. Chen, 2014, Vasculogenic mimicry: a novel target for glioma therapy., Chin. J. Cancer, 33, 74, 10.5732/cjc.012.10292 · DOI
  15. Cheng, 2013, Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth., Cell, 153, 139, 10.1016/j.cell.2013.02.021 · DOI · Paper page
  16. Cheng, 2011, L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1., EMBO J., 30, 800, 10.1038/emboj.2011.10 · DOI
  17. Cho, 2008, Therapeutic nanoparticles for drug delivery in cancer., Clin. Cancer Res., 14, 1310, 10.1158/1078-0432.CCR-07-1441 · DOI
  18. Clement, 2007, HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity., Curr. Biol., 17, 165, 10.1016/j.cub.2007.01.024 · DOI
  19. Cooke, 2012, Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway., Cancer Cell, 21, 66, 10.1016/j.ccr.2011.11.024 · DOI · Paper page
  20. Dahmane, 2001, The sonic hedgehog-gli pathway regulates dorsal brain growth and tumorigenesis., Development, 128, 5201, 10.1242/dev.128.24.5201 · DOI
  21. Dick, 2008, Stem cell concepts renew cancer research., Blood, 112, 4793, 10.1182/blood-2008-08-077941 · DOI
  22. Dufraine, 2008, Notch signaling regulates tumor angiogenesis by diverse mechanisms., Oncogene, 27, 5132, 10.1038/onc.2008.227 · DOI
  23. El Hallani, 2010, A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry., Brain, 133, 973, 10.1093/brain/awq044 · DOI
  24. Elsaesser, 2012, Toxicology of nanoparticles., Adv. Drug Deliv. Rev., 64, 129, 10.1016/j.addr.2011.09.001 · DOI
  25. Filbin, 2013, Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities., Nat. Med., 19, 1518, 10.1038/nm.3328 · DOI
  26. Folkins, 2009, Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1., Cancer Res., 69, 8216, 10.1158/0008-5472.CAN-09-0167 · DOI
  27. Gabathuler, 2010, Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases., Neurobiol. Dis., 37, 48, 10.1016/j.nbd.2009.07.028 · DOI
  28. Goodenberger, 2012, Genetics of adult glioma., Cancer Genet., 205, 613, 10.1016/j.cancergen.2012.10.009 · DOI
  29. Guichet, 2015, Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells., Stem Cells, 33, 21, 10.1002/stem.1767 · DOI
  30. Heddleston, 2009, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype., Cell Cycle, 8, 3274, 10.4161/cc.8.20.9701 · DOI · Paper page
  31. Hegi, 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma., N. Engl. J. Med., 352, 997, 10.1056/NEJMoa043331 · DOI · Paper page
  32. Heist, 2015, Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer., Proc. Natl. Acad. Sci. U.S.A., 112, 1547, 10.1073/pnas.1424024112 · DOI · Paper page
  33. Herve, 2008, CNS delivery via adsorptive transcytosis., AAPS J., 10, 455, 10.1208/s12248-008-9055-2 · DOI · Paper page
  34. Jain, 1987, Transport of molecules across tumor vasculature., Cancer Metastasis Rev., 6, 559, 10.1007/BF00047468 · DOI
  35. Jain, 2007, Angiogenesis in brain tumours., Nat. Rev. Neurosci., 8, 610, 10.1038/nrn2175 · DOI
  36. Jhanwar-Uniyal, 2015, Glioblastoma: molecular pathways, stem cells and therapeutic targets., Cancers, 7, 538, 10.3390/cancers7020538 · DOI
  37. Jhaveri, 2016, Tumor vasculature and glioma stem cells: contributions to glioma progression., Cancer Lett., 380, 545, 10.1016/j.canlet.2014.12.028** · DOI
  38. Jiang, 2014, Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment., Biomaterials, 35, 518, 10.1016/j.biomaterials.2013.09.094 · DOI
  39. Jin, 2016, The ID1-CULLIN3 axis regulates intracellular SHH and WNT signaling in glioblastoma stem cells., Cell Rep., 16, 1629, 10.1016/j.celrep.2016.06.092 · DOI
  40. Junttila, 2013, Influence of tumour micro-environment heterogeneity on therapeutic response., Nature, 501, 346, 10.1038/nature12626 · DOI · Paper page
  41. Kanamori, 2007, Contribution of Notch signaling activation to human glioblastoma multiforme., J. Neurosurg., 106, 417, 10.3171/jns.2007.106.3.417 · DOI
  42. Kim, 2015, Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine., Biochem. Biophys. Res. Commun., 468, 485, 10.1016/j.bbrc.2015.06.137 · DOI
  43. Kim, 2014, The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells., Mol. Ther., 22, 278, 10.1038/mt.2013.231 · DOI
  44. Kleihues, 1999, Primary and secondary glioblastomas: from concept to clinical diagnosis., Neuro Oncol., 1, 44, 10.1215/15228517-1-1-44 · DOI
  45. Kondo, 2014, Epigenetic dysregulation in glioma., Cancer Sci., 105, 363, 10.1111/cas.12379 · DOI
  46. Lasky, 2005, Notch signaling, brain development, and human disease., Pediatr. Res., 57(5 Pt 2), 104R, 10.1203/01.PDR.0000159632.70510.3D · DOI
  47. Lathia, 2010, Integrin alpha 6 regulates glioblastoma stem cells., Cell Stem Cell, 6, 421, 10.1016/j.stem.2010.02.018 · DOI
  48. Lee, 2008, Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells., Cancer Cell, 13, 69, 10.1016/j.ccr.2007.12.005 · DOI
  49. Lee, 2015, FoxM1 promotes stemness and radio-resistance of glioblastoma by regulating the master stem cell regulator Sox2., PLoS ONE, 10, 10.1371/journal.pone.0137703 · DOI
  50. Leong, 2006, Recent insights into the role of Notch signaling in tumorigenesis., Blood, 107, 2223, 10.1182/blood-2005-08-3329 · DOI
  51. Li, 2013, Altered expression of polycomb group genes in glioblastoma multiforme., PLoS ONE, 8, 10.1371/journal.pone.0080970 · DOI
  52. Liebelt, 2016, Glioma Stem Cells: Signaling, Microenvironment, and Therapy., Stem Cells Int., 2016, 10.1155/2016/7849890 · DOI
  53. Lu, 2006, Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration., Cancer Res., 66, 11878, 10.1158/0008-5472.CAN-06-2354 · DOI
  54. Lu, 2007, Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle., J. Control. Release, 118, 38, 10.1016/j.jconrel.2006.11.015 · DOI
  55. Lu, 2005, Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery., J. Control. Release, 107, 428, 10.1016/j.jconrel.2005.03.027 · DOI
  56. Mao, 2013, CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia., Neuro Oncol., 15, 865, 10.1093/neuonc/not029 · DOI
  57. Martinez, 2009, A microarray-based DNA methylation study of glioblastoma multiforme., Epigenetics, 4, 255, 10.4161/epi.9130 · DOI
  58. McEwen, 2004, Glucose transporter expression in the central nervous system: relationship to synaptic function., Eur. J. Pharmacol., 490, 13, 10.1016/j.ejphar.2004.02.041 · DOI · Paper page
  59. Metellus, 2011, Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution., Ann. Surg. Oncol., 18, 2937, 10.1245/s10434-011-1703-6 · DOI
  60. Nelson, 2004, Convergence of Wnt, beta-catenin, and cadherin pathways., Science, 303, 1483, 10.1126/science.1094291 · DOI
  61. Nystrom, 2012, Safety assessment of nanomaterials: implications for nanomedicine., J. Control. Release, 161, 403, 10.1016/j.jconrel.2012.01.027 · DOI
  62. Orza, 2013, Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles., Int. J. Nanomedicine, 8, 689, 10.2147/IJN.S37481 · DOI
  63. Ostrom, 2015, CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012., Neuro Oncol., 17(Suppl. 4), 10.1093/neuonc/nou327 · DOI
  64. Pardridge, 2006, Molecular Trojan horses for blood-brain barrier drug delivery., Discov. Med., 6, 139
  65. Paw, 2015, Mechanisms regulating glioma invasion., Cancer Lett., 362, 1, 10.1016/j.canlet.2015.03.015 · DOI
  66. Perrault, 2009, Mediating tumor targeting efficiency of nanoparticles through design., Nano Lett., 9, 1909, 10.1021/nl900031y · DOI
  67. Phillips, 2006, Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis., Cancer Cell, 9, 157, 10.1016/j.ccr.2006.02.019 · DOI
  68. Piccirillo, 2009, Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution., Oncogene, 28, 1807, 10.1038/onc.2009.27 · DOI
  69. Ping, 2011, The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling., J. Pathol., 224, 344, 10.1002/path.2908 · DOI
  70. Pohlmann, 2015, Real-time visualization of nanoparticles interacting with glioblastoma stem cells., Nano Lett., 15, 2329, 10.1021/nl504481k · DOI
  71. Prestegarden, 2010, Glioma cell populations grouped by different cell type markers drive brain tumor growth., Cancer Res., 70, 4274, 10.1158/0008-5472.CAN-09-3904 · DOI
  72. Purow, 2005, Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation., Cancer Res., 65, 2353, 10.1158/0008-5472.CAN-04-1890 · DOI
  73. Qin, 2010, In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes., J. Drug Target., 18, 536, 10.3109/10611861003587235 · DOI
  74. Rheinbay, 2013, An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma., Cell Rep., 3, 1567, 10.1016/j.celrep.2013.04.021 · DOI
  75. Ribatti, 2011, Vascular normalization: a real benefit?, Cancer Chemother. Pharmacol., 68, 275, 10.1007/s00280-011-1683-z · DOI
  76. Ricci-Vitiani, 2010, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells., Nature, 468, 824, 10.1038/nature09557 · DOI
  77. Risau, 1997, Mechanisms of angiogenesis., Nature, 386, 671, 10.1038/386671a0 · DOI · Paper page
  78. Rodriguez, 2012, Neoplastic cells are a rare component in human glioblastoma microvasculature., Oncotarget, 3, 98, 10.18632/oncotarget.427 · DOI
  79. Selvi, 2012, ATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptors., J. Nanobiotechnol., 10, 10.1186/1477-3155-10-35 · DOI
  80. Semenza, 2007, Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling., J. Cell. Biochem., 102, 840, 10.1002/jcb.21523 · DOI
  81. Seymour, 2015, Targeting aggressive cancer stem cells in glioblastoma., Front. Oncol., 5, 10.3389/fonc.2015.00159 · DOI
  82. Sherry, 2009, STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells., Stem Cells, 27, 2383, 10.1002/stem.185 · DOI · Paper page
  83. Signaroldi, 2016, Polycomb dysregulation in gliomagenesis targets a Zfp423-dependent differentiation network., Nat. Commun., 7, 10.1038/ncomms10753 · DOI
  84. Singh, 2004, Identification of human brain tumour initiating cells., Nature, 432, 396, 10.1038/nature03128 · DOI
  85. Soda, 2011, Transdifferentiation of glioblastoma cells into vascular endothelial cells., Proc. Natl. Acad. Sci. U.S.A., 108, 4274, 10.1073/pnas.1016030108 · DOI
  86. Son, 2009, SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma., Cell Stem Cell, 4, 440, 10.1016/j.stem.2009.03.003 · DOI
  87. Stricker, 2013, Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner., Genes Dev., 27, 654, 10.1101/gad.212662.112 · DOI
  88. Stupp, 2009, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial., Lancet Oncol., 10, 459, 10.1016/S1470-2045(09)70025-7 · DOI
  89. Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma., N. Engl. J. Med., 352, 987, 10.1056/NEJMoa043330 · DOI · Paper page
  90. Sugimori, 2015, Discovery of power-law growth in the self-renewal of heterogeneous glioma stem cell populations., PLoS ONE, 10, 10.1371/journal.pone.0135760 · DOI
  91. Suvà, 2014, Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like Cells., Cell, 157, 580, 10.1016/j.cell.2014.02.030 · DOI
  92. Suva, 2009, EZH2 is essential for glioblastoma cancer stem cell maintenance., Cancer Res., 69, 9211, 10.1158/0008-5472.CAN-09-1622 · DOI
  93. Tamura, 2013, Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy., J. Neurosurg., 119, 1145, 10.3171/2013.7.JNS122417 · DOI
  94. Tchoghandjian, 2010, A2B5 cells from human glioblastoma have cancer stem cell properties., Brain Pathol., 20, 211, 10.1111/j.1750-3639.2009.00269.x · DOI
  95. Thirant, 2012, Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor., Stem Cells, 30, 845, 10.1002/stem.1062 · DOI
  96. Tyagi, 2016, Exploiting Nanotechnology for the development of microRNA-based cancer therapeutics., J. Biomed. Nanotechnol., 12, 28, 10.1166/jbn.2016.2172 · DOI
  97. Wang, 2011, Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody., Nanomedicine, 7, 69, 10.1016/j.nano.2010.06.010 · DOI
  98. Wang, 2008a, CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells., Int. J. Cancer, 122, 761, 10.1002/ijc.23130 · DOI
  99. Wang, 2008b, c-Myc is required for maintenance of glioma cancer stem cells., PLoS ONE, 3, 10.1371/journal.pone.0003769 · DOI
  100. Wang, 2010, Glioblastoma stem-like cells give rise to tumour endothelium., Nature, 468, 829, 10.1038/nature09624 · DOI
  101. Wei, 2014, Brain tumor-targeted drug delivery strategies., Acta Pharm. Sin. B, 4, 193, 10.1016/j.apsb.2014.03.001 · DOI
  102. Weinberg, 2008, Coevolution in the tumor microenvironment., Nat. Genet., 40, 494, 10.1038/ng0508-494 · DOI
  103. Wong, 2013, The blood-brain barrier: an engineering perspective., Front. Neuroeng., 6, 10.3389/fneng.2013.00007 · DOI · Paper page
  104. Woodworth, 2014, Emerging insights into barriers to effective brain tumor therapeutics., Front. Oncol., 4, 10.3389/fonc.2014.00126 · DOI
  105. Wu, 2010, Role of sonic hedgehog signaling and the expression of its components in human embryonic stem cells., Stem Cell Res., 4, 38, 10.1016/j.scr.2009.09.002 · DOI
  106. Yahyanejad, 2016, NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma., Oncotarget, 7, 41251, 10.18632/oncotarget.9275 · DOI
  107. Yan, 2011, A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations., Proc. Natl. Acad. Sci. U.S.A., 108, 1591, 10.1073/pnas.1018696108 · DOI
  108. Yang, 2012, Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI., Biomaterials, 33, 1462, 10.1016/j.biomaterials.2011.10.071 · DOI
  109. Yao, 2015, Magnetic resonance nano-theranostics for glioblastoma multiforme., Curr. Pharm. Des., 21, 5256, 10.2174/1381612821666150923103307 · DOI
  110. Yao, 2013, Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells., PLoS ONE, 8, 10.1371/journal.pone.0057188 · DOI
  111. Yuan, 2004, Isolation of cancer stem cells from adult glioblastoma multiforme., Oncogene, 23, 9392, 10.1038/sj.onc.1208311 · DOI
  112. Zbinden, 2010, NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53., EMBO J., 29, 2659, 10.1038/emboj.2010.137 · DOI
  113. Zeppernick, 2008, Stem cell marker CD133 affects clinical outcome in glioma patients., Clin. Cancer Res., 14, 123, 10.1158/1078-0432.CCR-07-0932 · DOI
  114. Zhang, 2011, FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis., Cancer Cell, 20, 427, 10.1016/j.ccr.2011.08.016 · DOI
  115. Zheng, 2010, PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas., Cancer Cell, 17, 497, 10.1016/j.ccr.2010.03.020 · DOI
  116. Zhong, 2016, HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells., Oncotarget, 7, 44365, 10.18632/oncotarget.9744 · DOI
  117. Zhou, 2008, Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide., Clin. Cancer Res., 14, 1540, 10.1158/1078-0432.CCR-07-4544 · DOI
  118. Zhu, 2014, The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas., Neoplasma, 61, 401, 10.4149/neo_2014_049 · DOI

Cited by

Sorted by citations

See all 105

Metadata

Authors
Yi, Y., Hsieh, I.-Y., Huang, X., Li, J., & Zhao, W.
Venue
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Published
2016-12-07
Volume
7
ISSN
1663-9812
DOI
10.3389/fphar.2016.00477
PMC
PMC5141588
Cited by
105
References
3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review